Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS)
Amos Lal(Mayo Clinic in Arizona), Ognjen Gajic(Mayo Clinic in Arizona), Joshua L. Denson(Tulane University), Allan J. Walkey(Boston University), Donna Lee Armaignac(Baptist Health South Florida), Vishakha K. Kumar(Society of Critical Care Medicine), Matthew A. Warner(Mayo Clinic in Arizona), Karen Boman(Society of Critical Care Medicine), Vikas Bansal(Mayo Clinic in Florida), Aysun Tekin(Mayo Clinic), Simon Zec(Mayo Clinic in Arizona), Yasir Tarabichi(MetroHealth), Juan Pablo Domecq Garces(Mayo Clinic), Ashish Khanna(Atrium Health Wake Forest Baptist), Neha Deo(Mayo Clinic), Amy B. Christie(Navicent Health), Umamaheswara Raju(Gandhi Medical College & Hospital), Rodrigo Cartin‐Ceba, Sreekanth Cheruku, Rahul Kashyap(Pennsylvania State University), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center)
Cited by 14
Related Papers
Patient and service user engagement in research: a systematic review and synthesized framework
|Health Expectations|2013|660
Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition
|American Journal of Respiratory and Critical Care Medicine|2015|454
Approaches to Addressing Post–Intensive Care Syndrome among Intensive Care Unit Survivors. A Narrative Review
|Annals of the American Thoracic Society|2019|233